Christopher-Hennings Jane, Araujo Karla P C, Souza Carlos J H, Fang Ying, Lawson Steven, Nelson Eric A, Clement Travis, Dunn Michael, Lunney Joan K
1Jane Christopher-Hennings, Veterinary and Biomedical Sciences Department, South Dakota State University, N. Campus Drive, Brookings, SD 57007.
J Vet Diagn Invest. 2013 Nov;25(6):671-91. doi: 10.1177/1040638713507256. Epub 2013 Oct 23.
Bead-based multiplex assays (BBMAs) are applicable for high throughput, simultaneous detection of multiple analytes in solution (from several to 50-500 analytes within a single, small sample volume). Currently, few assays are commercially available for veterinary applications, but they are available to identify and measure various cytokines, growth factors and their receptors, inflammatory proteins, kinases and inhibitors, neurobiology proteins, and pathogens and antibodies in human beings, nonhuman primates, and rodent species. In veterinary medicine, various nucleic acid and protein-coupled beads can be used in, or for the development of, antigen and antibody BBMAs, with the advantage that more data can be collected using approximately the same amount of labor as used for other antigen and antibody assays. Veterinary-related BBMAs could be used for detection of pathogens, genotyping, measurement of hormone levels, and in disease surveillance and vaccine assessment. It will be important to evaluate whether BBMAs are "fit for purpose," how costs and efficiencies compare between assays, which assays are published or commercially available for specific veterinary applications, and what procedures are involved in the development of the assays. It is expected that many veterinary-related BBMAs will be published and/or become commercially available in the next few years. The current review summarizes the BBMA technology and some of the currently available BBMAs developed for veterinary settings. Some of the human diagnostic BBMAs are also described, providing an example of possible templates for future development of new veterinary-related BBMAs.
基于微珠的多重分析(BBMAs)适用于高通量同时检测溶液中的多种分析物(在单个小样本体积内可检测几种至50 - 500种分析物)。目前,很少有适用于兽医应用的商业检测方法,但可用于识别和测量人类、非人灵长类动物和啮齿类动物中的各种细胞因子、生长因子及其受体、炎症蛋白、激酶和抑制剂、神经生物学蛋白、病原体和抗体。在兽医学中,各种核酸和蛋白质偶联微珠可用于抗原和抗体BBMAs的检测或开发,其优点是使用与其他抗原和抗体检测大致相同的工作量可收集更多数据。与兽医相关的BBMAs可用于病原体检测、基因分型、激素水平测量以及疾病监测和疫苗评估。评估BBMAs是否“适用”、不同检测方法的成本和效率如何比较、哪些检测方法已发表或可用于特定兽医应用以及检测方法开发涉及哪些程序将很重要。预计未来几年将有许多与兽医相关的BBMAs发表和/或上市。本综述总结了BBMA技术以及一些目前为兽医环境开发的可用BBMAs。还描述了一些人类诊断用BBMAs,为未来开发新的兽医相关BBMAs提供了可能的模板示例。